• Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany

  • Study of DCC-3084 alone and with other cancer drugs in patients with advanced solid tumors driven by the MAPK pathway

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Spain

  • Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria France Germany The Netherlands Poland +1

  • Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany

  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany

  • Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria France Germany Italy Poland Spain

  • Study of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Portugal +1

  • Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Germany Italy The Netherlands Poland Spain

powered by